Non-communicable diseases have surpassed infectious diseases as the leading cause of morbidity and mortality in developed countries. Prevention and treatment of the causes and consequences of lifestyle-related diseases forms an important part of health policy in the twenty-first century. Public...

Contents: Preface -- Part I: Active learning assignments -- 1. Introduction to learning and teaching health economics / Allen C. Goodman and Maia Platt -- 2. The health insurance game / Jennifer Kohn -- 3. Assessing competency in health economics using portfolios / Neha Batura, Hassan...

This article addresses costs and utilization for mental health/substance abuse treatment, with particular emphasis on the emerging importance of self-insured coverage in the 1990s. We estimate drug abuse treatment demand and utilization with an insurance claims database from self-insured...

‘Menorrhagia’, or heavy menstrual bleeding, is a common problem affecting women. The principal driver for treatment is women's experience of its interference in their lives, so a measure of quality of life (QoL) is increasingly used as the primary outcome to assess treatment success. QoL...

An examination of the willingness to pay values elicited from more than 3000 persons involved in three independent studies revealed that the majority had offered one of a limited number of values from the ranges available to them. These values were 'prominent numbers', the use of which has been...

Health economists use “willingness-to-pay” to assess the prospective value of novel interventions. The technique remains controversial, not least with respect to the formats under which values are elicited. The paper analyses the results of a series of studies of the same intervention valued...